Proportion of pathogenic mutations detected in BRCA1/2 and non-BRCA1/2 genes.</p
<p>OR: odds ratio</p><p>Proportion of epidemiologically protective mutations at two unlinked loci un...
<p>Distribution of the number of mutations according to mutational signatures in HR+/HER2− metastati...
<p>Frequencies of mutations detected with the screening test targeting founder and recurrent <i>loci...
(Excluding n = 41 probands who underwent predictive testing) Proportion of Pathogenic Mutations by E...
<p>The Percentage of Cases of MDS and AML Harboring Specific Classes of Genetic Mutations</p
<p>A). Percentage of the indicated mutations detected in the primary analysis. B) Percentage of muta...
<p>Distribution of pathogenic mutations reported out in first 3,000 patient samples referred for BRC...
<p>The molecular diagnosis statistics of 99 RP patients: A. The percentage of different types of pat...
Percent distribution of monogenic variants identified in genes according to the CH phenotype.</p
Odds of Pathogenicity Calculations for the Current BRCA1 Variant Functional Classifications.</p
<p>The frequency of mutations detected in <i>BRCA1/2</i> with NGS among 454 individuals, per year an...
Genotype distribution of the genetic variants investigated, expressed in percentages.</p
(A) The number and frequency of each mutation type among 36 deleterious variants. (B) The mutation f...
<p>OR: odds ratio</p><p>Proportion of epidemiologically protective mutations at a single locus under...
<p>B: The number of mutations/mutation candidates in the early-onset group. C: The number of mutatio...
<p>OR: odds ratio</p><p>Proportion of epidemiologically protective mutations at two unlinked loci un...
<p>Distribution of the number of mutations according to mutational signatures in HR+/HER2− metastati...
<p>Frequencies of mutations detected with the screening test targeting founder and recurrent <i>loci...
(Excluding n = 41 probands who underwent predictive testing) Proportion of Pathogenic Mutations by E...
<p>The Percentage of Cases of MDS and AML Harboring Specific Classes of Genetic Mutations</p
<p>A). Percentage of the indicated mutations detected in the primary analysis. B) Percentage of muta...
<p>Distribution of pathogenic mutations reported out in first 3,000 patient samples referred for BRC...
<p>The molecular diagnosis statistics of 99 RP patients: A. The percentage of different types of pat...
Percent distribution of monogenic variants identified in genes according to the CH phenotype.</p
Odds of Pathogenicity Calculations for the Current BRCA1 Variant Functional Classifications.</p
<p>The frequency of mutations detected in <i>BRCA1/2</i> with NGS among 454 individuals, per year an...
Genotype distribution of the genetic variants investigated, expressed in percentages.</p
(A) The number and frequency of each mutation type among 36 deleterious variants. (B) The mutation f...
<p>OR: odds ratio</p><p>Proportion of epidemiologically protective mutations at a single locus under...
<p>B: The number of mutations/mutation candidates in the early-onset group. C: The number of mutatio...
<p>OR: odds ratio</p><p>Proportion of epidemiologically protective mutations at two unlinked loci un...
<p>Distribution of the number of mutations according to mutational signatures in HR+/HER2− metastati...
<p>Frequencies of mutations detected with the screening test targeting founder and recurrent <i>loci...